NASDAQ

Pacira BioSciences, Inc. (PCRX)

510 Thanks from members

Pacira BioSciences exhibits a complex market sentiment, balancing solid EXPAREL revenue growth and new reimbursement catalysts against an activist proxy battle and strategic portfolio restructuring.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →